NRP1 and colonic neoplasm: To investigate whether iRGD-Exos could combine with NRP-1-positive colon cancer cells and deliver AMO into tumor cells, AMO was pre-labeled with fluorescein amidite (FAM) before being loaded into exosomes, and was co-cultured with human colon cancer cell lines and 293T cells.